What the Research Says
Ashwagandha (Withania somnifera) is one of the most studied adaptogenic herbs in Ayurvedic medicine. Modern clinical research has focused on standardized root extracts — primarily KSM-66 (5% withanolides) and Sensoril (35% withanolide glycosides).
A landmark 2012 double-blind RCT (n=64) by Chandrasekhar et al. found 300mg KSM-66 twice daily for 60 days produced statistically significant reductions in all stress-assessment scores, reduced serum cortisol by 27.9%, and improved the safety profile. A 2019 RCT (n=60) found ashwagandha (240mg Sensoril/day for 60 days) significantly reduced cortisol, anxiety (GAD-7), and improved subjective sleep quality.
Adaptogen Mechanisms
- HPA axis modulation: Withanolides reduce HPA axis reactivity, blunting excessive cortisol release
- GABA receptor activity: Some withanolides bind GABA-A receptors, contributing to anxiolytic and sleep-promoting effects
- Nrf2 pathway: Upregulates antioxidant defenses
- Thyroid modulation: Some evidence for mild TSH/T4 increases
- Anti-inflammatory: Inhibits NF-κB, reducing pro-inflammatory cytokines
Clinical Benefits
- Significant reductions in perceived stress (PSS scale)
- 27–30% reductions in serum cortisol
- Improved sleep quality and onset latency
- Reduced anxiety symptoms (GAD-7 improvements)
- Improved physical performance and recovery
- Possible testosterone support in stressed men (2 trials)
KSM-66 vs Sensoril
- KSM-66: Root-only extract, 5% withanolides. Most studied for energy, performance, fertility. Dose: 300–600mg/day.
- Sensoril: Root + leaf extract, 35% withanolide glycosides. Often studied for stress and sleep. Dose: 125–250mg/day.
- Both have solid clinical evidence; choice depends on desired effect
Dosage Protocols
- KSM-66: 300mg twice daily or 600mg once daily
- Sensoril: 125–250mg/day
- Duration: Effects emerge at 4 weeks; full effect at 8–12 weeks
- With food: Recommended to reduce GI upset
Safety & Interactions
- Generally well tolerated at recommended doses
- Thyroid: May increase T3/T4; monitor if on thyroid medication
- Sedatives: Additive effects possible with benzodiazepines
- Pregnancy: Traditionally contraindicated; avoid
Frequently Asked Questions
Yes — multiple RCTs demonstrate statistically significant cortisol reductions with standardized ashwagandha extracts. The most cited study found a 27.9% cortisol reduction at 600mg KSM-66/day over 60 days. Effects are most pronounced in chronically stressed individuals.
Most clinical studies see measurable effects after 4 weeks, with full benefit typically at 8 weeks. Consistent daily use is important — it is not an acute-acting supplement.
Both are well-researched standardized extracts. KSM-66 is more studied for energy, performance, and testosterone support. Sensoril is often preferred for stress and sleep due to higher withanolide concentration per gram.
Multiple trials show improvements in sleep quality with ashwagandha, likely via GABA receptor activity and cortisol reduction. A 2019 study found significant improvements on sleep quality indices with Sensoril 240mg/day for 60 days.
Clinical trials up to 60–90 days show good tolerability. Long-term data beyond 3 months is limited. Generally considered safe for healthy adults at recommended doses. Those with thyroid conditions or on medications should consult a healthcare provider.
Research Summary
Ashwagandha standardized extracts have moderate clinical evidence for stress reduction, cortisol lowering, and sleep improvement. KSM-66 and Sensoril are the best-studied forms.
- Evidence strength: Moderate (3/5)
- Best forms: KSM-66 (600mg/day) or Sensoril (240mg/day)
- Key benefit: 27–30% cortisol reduction in stressed adults
- Duration: 4–8 weeks for full effect
- Notable: Also improves sleep and anxiety scores
References
All studies cited are peer-reviewed and publicly accessible. DOI and PubMed links open in a new tab.
- 1. Chandrasekhar K, Kapoor J, Anishetty S (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262. doi:10.4103/0253-7176.106022 PMID:23439798
- 2. Pratte MA, Nanavati KB, Young V, Morley CP (2014). An Alternative Treatment for Anxiety: A Systematic Review of Human Trial Results Reported for the Ayurvedic Herb Ashwagandha (Withania somnifera). Journal of Alternative and Complementary Medicine, 20(12), 901–908. doi:10.1089/acm.2014.0177 PMID:25405876
- 3. Langade D, Kanchi S, Salve J, Debnath K, Ambegaokar D (2019). Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus, 11(9), e5797. doi:10.7759/cureus.5797 PMID:31728244
- 4. Auddy B, Hazra J, Mitra A, Abedon B, Ghosal S (2008). A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: A double-blind, randomized, placebo-controlled study. Journal of the American Nutraceutical Association, 11(1), 50–56.
- 5. Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition, 12, 43. doi:10.1186/s12970-015-0104-9 PMID:26609282